Biological activity and coordination modes of copper(II) complexes of Schiff base-derived coumarin ligands

Dalton Transactions

Volumn 39, Issue 45, 2010, Pages 10854-10865

  Creaven, Bernadette Sarah ^a   Czeglédi, Eszter ^b   Devereux, Michael ^a   Enyedy, Éva Anna ^b   Foltyn Arfa Kia, Agnieszka ^a   Karcz, Dariusz ^a   Kellett, Andrew ^a   McClean, Siobhán ^a   Nagy, Nóra Veronika ^c   Noble, Andy ^d   Rockenbauer, Antal ^c   Szabó Plánka, Terézia ^b   Walsh, Maureen ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b UNIVERSITY OF SZEGED   (Hungary)

^c CHEMICAL RESEARCH CENTER   (Hungary)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE COMPLEXES; BIOLOGICAL ACTIVITIES; CANDIDA; COORDINATION MODES; COPPER (II); COPPER COMPLEXES; FROZEN SOLUTIONS; HUMAN BREAST CANCER CELLS; HUMAN COLON CANCER; POTENTIOMETRIC; SCHIFF-BASE; SCHIFF-BASE LIGANDS; SECONDARY AMINES; SOLUBILITY CHARACTERISTICS; SPECTROSCOPIC METHOD; UV-VIS SPECTROSCOPIC METHOD;

COPPER; COPPER COMPOUNDS; FUNCTIONAL GROUPS; PHENOLS; SPECTROSCOPIC ANALYSIS; YEAST;

LIGANDS;

AMINE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; COPPER; COUMARIN; COUMARIN DERIVATIVE; LIGAND; ORGANOMETALLIC COMPOUND; SCHIFF BASE;

ARTICLE; BACTERIUM; CANDIDA; CHEMISTRY; DRUG EFFECT; ELECTRON SPIN RESONANCE; HUMAN; PH; POTENTIOMETRY; SOLUBILITY; SYNTHESIS; TUMOR CELL LINE;

AMINES; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; CANDIDA; CELL LINE, TUMOR; COPPER; COUMARINS; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; HYDROGEN-ION CONCENTRATION; LIGANDS; ORGANOMETALLIC COMPOUNDS; POTENTIOMETRY; SCHIFF BASES; SOLUBILITY;

EID: 78149455065     PISSN: 14779226     EISSN: 14779234     Source Type: Journal    
DOI: 10.1039/c0dt00068j     Document Type: Article

References (38)

1. D. C. Hooper J. S. Wolfson G. L. McHugh M. B. Winters M. N. Swartz Antimicrob. Agents Chemother. 1982 22 662 671
2. U. Glam S. Heller S. Shapiro M. Page S. Li L. Heide Antimicrob. Agents Chemother. 2004 48 1307 131
3. T. Okamoto T. Kobayashi S. Yoshida Curr. Med. Chem. 2005 5 47 51
4. A. Lacy R. O'Kennedy Curr. Pharm. Des. 2004 10 3797 3811
5. G. J. Finn B. S. Creaven D. Egan Cancer Lett. 2004 214 43 54
6. G. J. Finn B. S. Creaven D. Egan Eur. J. Pharm. Sci. 2005 26 16 25
7. B. S. Creaven D. A. Egan K. Kavanagh M. McCann M. Mahon A. Noble B. Thati M. Walsh Polyhedron 2005 24 949 957
8. B. S. Creaven D. A. Egan K. Kavanagh M. McCann M. Mahon A. Noble B. Thati M. Walsh Inorg. Chim. Acta 2006 359 3976 3984
9. B. S. Creaven D. A. Egan D. Karcz K. Kavanagh M. McCann M. Mahon A. Noble B. Thati M. Walsh J. Inorg. Biochem. 2007 101 1108 1119
10. B. S. Creaven M. Devereux A. Foltyn S. McClean G. Rosair V. R. Thangella M. Walsh Polyhedron 2010 29 813 822
11. B. S. Creaven M. Devereux D. Karcz A. Kellett M. McCann A. Noble M. Walsh J. Inorg. Biochem. 2009 103 1196 1203
12. S. U. Rehman Z. H. Chohan F. Gulnaz C. T. Supuran J. Enzyme Inhib. Med. Chem. 2005 20 333 340
13. G. B. Bagihalli P. G. Avaji S. A. Patil P. S. Badami Eur. J. Med. Chem. 2008 43 2639 2649
14. K. B. Gudasi M. S. Patil R. S. Vadavi Eur. J. Med. Chem. 2008 43 2436 2441
15. T. Szabó-Plánka G. Peintler A. Rockenbauer M. Gyr M. Varga-Fábián L. Institórisz L. Balázspiri J. Chem. Soc., Dalton Trans. 1989 1925 1932
16. T. Szabó-Plánka B. Gyurcsik N. V. Nagy A. Rockenbauer R. ípo J. ima M. Melník J. Inorg. Biochem. 2008 102 101 109
17. R. ípo T. Szabó-Plánka A. Rockenbauer N. V. Nagy J. ima M. Melník I. Nagypál J. Phys. Chem. A 2008 112 10280 10286
18. G. Gran Acta Chem. Scand. 1950 4 559 577
19. G. M. Sheldrick, ShelX-86, Program for the Solution of Crystal Structures, University of Göttingen, Germany 1986 G. M. Sheldrick, ShelX-97, Program for the Crystal Structure Refinement, University of Göttingen, Germany 1997
20. NCCL (National Committee for Clinical Laboratory) publication, Villanova, PA, M27-P, 1979
21. T. Mosmann J. Immunol. Methods 1983 65 55 63
22. H. M. Irving M. G. Miles L. D. Pettit Anal. Chim. Acta 1967 38 475 488
23. M. Georgieva G. Velinov O. Budevsky Anal. Chim. Acta 1977 90 83 89
24. H. R. Jiménez M. Julve J. Faus J. Chem. Soc., Dalton Trans. 1991 1945 1949
25. A. Sabatini A. Vacca P. Gans Talanta 1974 21 53 77
26. L. Zékány, I. Nagypál, in Computational Methods for the Determination of Stability Constants, Plenum Press, New York, 1985, pp. 291-353
27. A. Rockenbauer L. Korecz Appl. Magn. Reson. 1996 10 29 43
28. B. Thati A. Noble B. S. Creaven M. Walsh M. McCann M. Devereux K. Kavanagh D. A. Egan Eur. J. Pharmacol. 2009 602 203 214
29. B. Thati A. Noble B. S. Creaven M. Walsh M. McCann K. Kavanagh M. Devereux D. A. Egan Cancer Lett. 2007 250 128 139
30. B. Thati A. Noble B. S. Creaven M. Walsh K. Kavanagh D. A. Egan Eur. J. Pharmacol. 2007 569 16 28
31. B. Thati A. Noble B. S. Creaven M. Walsh K. Kavanagh D. A. Egan Chem.-Biol. Interact. 2007 168 143 158
32. B. Thati A. Noble B. S. Creaven M. Walsh M. McCann K. Kavanagh M. Devereux D. A. Egan Cancer Lett. 2007 248 321 331
33. A. Noble R. Rowan B. S. Creaven M. Walsh M. McCann D. Egan K. Kavanagh Toxicol. in Vitro 2007 21 801 808
34. P. Perego M. De Cesare P. De Isabella N. Carenini G. Beggiolin G. Pezzoni M. Palumbo L. Tartaglia G. Pratesi C. Pisano P. Carminati G. L. Scheffer F. Zunino Cancer Research 2001 61 6034 6037
35. R. Hernández-Molina A. Mederos P. Gili S. Domínguez P. Nunez Polyhedron 1997 16 4191 4196
36. R. Hernández-Molina A. Mederos P. Gili S. Domínguez F. Lloret J. Cano M. Julve C. Ruiz-Perez X. Solans J. Chem. Soc., Dalton Trans. 1997 4327 4334
37. J. Balla T. Kiss R. F. Jameson Inorg. Chem. 1992 31 58 62
38. T. Rosu E. Pahontu C. Maxim E. Georgescu N. Stanica G. L. Almajan A. Gulea Polyhedron 2010 29 757 766